Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115112) titled 'A Prospective, Single-Arm, Multicenter Study on the Efficacy and Safety of Lisaftoclax Combined with Rituximab and Lenalidomide Regimen in the Treatment of Previously Untreated Elderly Patients with Mantle Cell Lymphoma' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University
Condition:
Mantle Cell Lymphoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-23
Target Sample Size: Experimental group:40;
Countries of Recruitment:
China
To know more, ...